1.2 New uses

What are new uses?

The problem whether new uses of known substances should be patented occurs in the pharmaceutical context where a known product is used as a medicament for the first time (first medical use) or where a new medical use of a medicament is discovered (second medical use).

First medical use would, for instance, be the case where a substance used for food consumption is later found to prevent cancer. The question of patentability of second medical uses arises where a drug is traditionally used to combat cancer but later discovered to be effective against HIV/AIDS, such as Retrovir (AZT). Another case of new uses is finding a new, more efficient or less invasive way of administering a known drug.

For you as a legislator, the new use discussion might be particularly relevant in the context of patenting new uses of substances familiar from traditional knowledge or substances occurring in nature.

IDevice Icon Please note
The issue of new uses is very complex. This module provides you with the basics by presenting various options as to how new uses could be dealt with in your domestic laws. The new use question will be discussed both under patentable subject matter and under patentability criteria (see chapter 2.4). This distinction has to be made as process patents on new uses can be considered as non-patentable subject matter, whereas product patents can only be excluded by strictly applying the patentability criteria.